GSK Cancer R&D Chief Sees Three Key Approvals In Q2

Says “Will Help Anchor” Oncology Pipeline.

 
• By Sten Stovall
Cancer_Research
Axel Hoos says GSK is successfully re-entering oncology’s commercial space • Source: Shutterstock

More from New Products

More from Scrip